Clinical Trial: The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)

U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07512856) titled 'The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)' on March 22.

Brief Summary: This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.

Study Start Date: Feb. 01, 2024

Study Type: INTERVENTIONAL

Condition: HIV Prevention Substance Use Mental Health Disorders Sexually Transmitted Infections (STIs) Chemsex

Intervention: BEHA...